Lv4
500 积分 2025-07-27 加入
Etoposide plus cytarabine versus cyclophosphamide or melphalan in busulfan-based preparative regimens for autologous stem cell transplantation in adults with acute myeloid leukemia in first complete remission: a study from the Acute Leukemia Working Party of the EBMT
13天前
已完结
High incidence of severe TA-TMA increases mortality in adult allogeneic transplant recipients: a prospective MIDAS Consortium study
1个月前
已完结
Validation of risk stratification and novel prognostic biomarkers in asian adult HSCT recipients with TA-TMA: A multicenter real-world study
1个月前
已完结
Autologous Transplant or CAR‐T as Consolidation Options in MYC Rearranged Large B‐Cell Lymphoma Patients in Remission After Salvage Treatments
3个月前
已完结
An ASTCT, CIBMTR, EBMT, and APBMT Consensus Statement Defining Response Criteria for Hematopoietic Cell Transplantation Associated Thrombotic Microangiopathy (TA-TMA) Directed Therapy
3个月前
已完结
Translating biomarker insights into practice: a path forward in TA-TMA management
3个月前
已完结
How I Evaluate and Treat Resistance and Relapse in CML
7个月前
已关闭
How I Treat AML relapse after allogeneic HCT
7个月前
已完结
Genetic risk classification for adults with AML receiving less-intensive therapies: the 2024 ELN recommendations
7个月前
已完结
Refined ELN 2024 risk stratification improves survival prognostication following venetoclax-based therapy in AML
7个月前
已完结
皖公网安备34019202002308
